BioSpace News Archive

XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson’s Disease Treatment

XPhyto Therapeutics Corp. is pleased to report the results of its Rotigotine transdermal patch human skin cadaver study and dissolution data.

October 18, 2022
·
5 min read
bioLytical Laboratories Inc. receives WHO PQ for its iStatis COVID-19 Antigen Home Test

bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced it has received its WHO PQ for its self-test, the iStatis COVID-19 Antigen Home Test, allowing its immediate entry into international markets.

October 18, 2022
·
4 min read
BioMidwest

Surgical experts publish updated MRONJ guidance

The American Association of Oral and Maxillofacial Surgeons has issued updated guidance for treating a rare but potentially serious jawbone condition that can impact patients taking antiresorptive medications to treat certain cancer types.

October 18, 2022
·
6 min read
Business

Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer

Abalos Therapeutics announced the appointment of Thomas Bogenrieder, MD, PhD, as Chief Medical Officer.

October 18, 2022
·
3 min read
Genetown

Optibrium Expands Operations in North America for AI and Computational Drug Discovery Technologies

Optibrium, a leading developer of software and artificial intelligence solutions for drug discovery, announced the opening of its US subsidiary, Optibrium Inc., and the promotion of Dr Tamsin Mansley to President of the new subsidiary to lead its US-based team and business operations.

October 18, 2022
·
2 min read
Genetown

Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Fall

Arch Therapeutics, Inc. today announced that its novel product, AC5 ® Advanced Wound System (“AC5”), was featured at the 2022 Symposium on Advanced Wound Care (SAWC) Fall.

October 18, 2022
·
5 min read
Pharm Country

Merck and the Bill & Melinda Gates Medical Research Institute Announce Licensing Agreement for Novel Tuberculosis Antibiotic Candidates

Merck, known as MSD outside of the United States and Canada, and the Bill & Melinda Gates Medical Research Institute announced a licensing agreement for two preclinical antibacterial candidates for evaluation as potential components of combination regimens for the treatment of tuberculosis.

October 18, 2022
·
6 min read
Biotech Bay

NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces significant orders for DERMAdoctor ® Kakadu ® C 20% Vitamin C Serum with Ferulic Acid & Vitamin E.

October 18, 2022
·
4 min read
Pharm Country

Indaptus Therapeutics to Present at the LD Micro Main Event XV

Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer will present a corporate overview at the LD Micro Main Event XV.

October 18, 2022
·
4 min read
Lone Star Bio

Plus Therapeutics to Present at the ThinkEquity Conference

Plus Therapeutics, Inc. announced today that Marc Hedrick, M.D., President and Chief Executive Officer, will present at the ThinkEquity Conference on Wednesday, October 26, 2022, at 3:00 p.m. ET, and host investor meetings.

October 18, 2022
·
4 min read